nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—obesity	0.741	1	CbGaD
Tyloxapol—LPL—brown adipose tissue—obesity	0.0288	0.39	CbGeAlD
Tyloxapol—LPL—hindbrain—obesity	0.00942	0.128	CbGeAlD
Tyloxapol—LPL—respiratory system—obesity	0.00576	0.0779	CbGeAlD
Tyloxapol—LPL—adrenal cortex—obesity	0.00483	0.0654	CbGeAlD
Tyloxapol—LPL—cardiovascular system—obesity	0.00441	0.0596	CbGeAlD
Tyloxapol—LPL—pituitary gland—obesity	0.0039	0.0528	CbGeAlD
Tyloxapol—LPL—adipose tissue—obesity	0.00389	0.0526	CbGeAlD
Tyloxapol—LPL—digestive system—obesity	0.00366	0.0495	CbGeAlD
Tyloxapol—LPL—adrenal gland—obesity	0.00349	0.0472	CbGeAlD
Tyloxapol—LPL—endocrine gland—obesity	0.00302	0.0409	CbGeAlD
Tyloxapol—LPL—liver—obesity	0.00273	0.0369	CbGeAlD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	7.99e-05	0.000432	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—UCP2—obesity	7.86e-05	0.000424	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ECHS1—obesity	7.86e-05	0.000424	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HSD11B1—obesity	7.86e-05	0.000424	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—UCP3—obesity	7.86e-05	0.000424	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CD36—obesity	7.74e-05	0.000418	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ADH1B—obesity	7.74e-05	0.000418	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PNLIP—obesity	7.73e-05	0.000417	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOB—obesity	7.62e-05	0.000411	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GPAM—obesity	7.62e-05	0.000411	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ACSL1—obesity	7.62e-05	0.000411	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARGC1B—obesity	7.62e-05	0.000411	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SDC3—obesity	7.55e-05	0.000407	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IL6—obesity	7.42e-05	0.000401	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PCK1—obesity	7.39e-05	0.000399	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HADH—obesity	7.39e-05	0.000399	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—FADS1—obesity	7.39e-05	0.000399	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NPY5R—obesity	7.38e-05	0.000398	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PMCH—obesity	7.38e-05	0.000398	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HCRT—obesity	7.38e-05	0.000398	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NMU—obesity	7.38e-05	0.000398	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PPARA—obesity	7.2e-05	0.000389	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ACP5—obesity	7.19e-05	0.000388	CbGpPWpGaD
Tyloxapol—LPL—Disease—RBP4—obesity	7.12e-05	0.000384	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—GPX1—obesity	7.1e-05	0.000383	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NPY2R—obesity	7.07e-05	0.000382	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NPY1R—obesity	7.07e-05	0.000382	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MC4R—obesity	7.07e-05	0.000382	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MC3R—obesity	7.07e-05	0.000382	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—G6PD—obesity	7.01e-05	0.000378	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PPY—obesity	6.94e-05	0.000374	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SREBF2—obesity	6.92e-05	0.000374	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HK1—obesity	6.92e-05	0.000374	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CD36—obesity	6.92e-05	0.000373	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—LEP—obesity	6.83e-05	0.000369	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HDAC8—obesity	6.81e-05	0.000367	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GIP—obesity	6.81e-05	0.000367	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKCH—obesity	6.81e-05	0.000367	CbGpPWpGaD
Tyloxapol—LPL—Disease—CST3—obesity	6.74e-05	0.000364	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRKAR2B—obesity	6.74e-05	0.000364	CbGpPWpGaD
Tyloxapol—LPL—Disease—DCN—obesity	6.69e-05	0.000361	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LPA—obesity	6.69e-05	0.000361	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LPIN1—obesity	6.54e-05	0.000353	CbGpPWpGaD
Tyloxapol—LPL—Disease—NCF2—obesity	6.51e-05	0.000351	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LEPR—obesity	6.47e-05	0.000349	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARA—obesity	6.43e-05	0.000347	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOA5—obesity	6.41e-05	0.000346	CbGpPWpGaD
Tyloxapol—LPL—Disease—NAMPT—obesity	6.38e-05	0.000345	CbGpPWpGaD
Tyloxapol—LPL—Disease—GCK—obesity	6.34e-05	0.000342	CbGpPWpGaD
Tyloxapol—LPL—Disease—IAPP—obesity	6.3e-05	0.00034	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOC3—obesity	6.3e-05	0.00034	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—AGT—obesity	6.23e-05	0.000336	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC22A1—obesity	6.12e-05	0.00033	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CLOCK—obesity	6.12e-05	0.00033	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOE—obesity	6.1e-05	0.000329	CbGpPWpGaD
Tyloxapol—LPL—Disease—SDC1—obesity	6.05e-05	0.000327	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CAV1—obesity	6.04e-05	0.000326	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOA1—obesity	6.03e-05	0.000326	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SULT2A1—obesity	5.96e-05	0.000322	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GLP1R—obesity	5.96e-05	0.000322	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKR1C3—obesity	5.95e-05	0.000321	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PPARG—obesity	5.95e-05	0.000321	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—DPYD—obesity	5.86e-05	0.000316	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—INS—obesity	5.84e-05	0.000315	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRB3—obesity	5.79e-05	0.000312	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GAL—obesity	5.65e-05	0.000305	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PRKAR2B—obesity	5.64e-05	0.000305	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT2—obesity	5.64e-05	0.000304	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—DCN—obesity	5.6e-05	0.000302	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—C5AR1—obesity	5.59e-05	0.000302	CbGpPWpGaD
Tyloxapol—LPL—Disease—GOT2—obesity	5.53e-05	0.000299	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CG—obesity	5.51e-05	0.000297	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CPT1A—obesity	5.45e-05	0.000294	CbGpPWpGaD
Tyloxapol—LPL—Disease—FASN—obesity	5.42e-05	0.000292	CbGpPWpGaD
Tyloxapol—LPL—Disease—PARP1—obesity	5.39e-05	0.000291	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NAMPT—obesity	5.35e-05	0.000289	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PPARG—obesity	5.31e-05	0.000287	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GCK—obesity	5.31e-05	0.000287	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LIPC—obesity	5.31e-05	0.000287	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOC3—obesity	5.28e-05	0.000285	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—POMC—obesity	5.24e-05	0.000283	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TYK2—obesity	5.21e-05	0.000281	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RHOA—obesity	5.17e-05	0.000279	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CETP—obesity	5.12e-05	0.000277	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCK—obesity	5.11e-05	0.000276	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKG1—obesity	5.11e-05	0.000276	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS1—obesity	5.07e-05	0.000274	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SDC1—obesity	5.07e-05	0.000274	CbGpPWpGaD
Tyloxapol—LPL—Disease—TCF7L2—obesity	5.02e-05	0.000271	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKR1C3—obesity	4.99e-05	0.000269	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RBP4—obesity	4.98e-05	0.000269	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GLP1R—obesity	4.98e-05	0.000269	CbGpPWpGaD
Tyloxapol—LPL—Disease—SLC2A4—obesity	4.93e-05	0.000266	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SCARB1—obesity	4.91e-05	0.000265	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCKAR—obesity	4.9e-05	0.000265	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HRH3—obesity	4.9e-05	0.000265	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CD—obesity	4.84e-05	0.000261	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ALB—obesity	4.78e-05	0.000258	CbGpPWpGaD
Tyloxapol—LPL—Disease—GOT1—obesity	4.78e-05	0.000258	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SREBF1—obesity	4.76e-05	0.000257	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKAR2B—obesity	4.72e-05	0.000255	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRL—obesity	4.71e-05	0.000254	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GOT2—obesity	4.63e-05	0.00025	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3R1—obesity	4.57e-05	0.000247	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NCF2—obesity	4.56e-05	0.000246	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—FASN—obesity	4.54e-05	0.000245	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—BCHE—obesity	4.52e-05	0.000244	CbGpPWpGaD
Tyloxapol—LPL—Disease—FOXO3—obesity	4.48e-05	0.000242	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NPY—obesity	4.44e-05	0.00024	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOC3—obesity	4.41e-05	0.000238	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IAPP—obesity	4.41e-05	0.000238	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2E1—obesity	4.36e-05	0.000235	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NQO1—obesity	4.31e-05	0.000233	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CRH—obesity	4.29e-05	0.000231	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HTR1B—obesity	4.29e-05	0.000231	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SDC1—obesity	4.24e-05	0.000229	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CB—obesity	4.22e-05	0.000228	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS2—obesity	4.18e-05	0.000226	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKR1C3—obesity	4.17e-05	0.000225	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GCG—obesity	4.13e-05	0.000223	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC2A4—obesity	4.13e-05	0.000223	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP9—obesity	4.11e-05	0.000222	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYCS—obesity	4.08e-05	0.00022	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NPS—obesity	4.06e-05	0.000219	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOB—obesity	4.05e-05	0.000219	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GGT1—obesity	4e-05	0.000216	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GOT1—obesity	4e-05	0.000216	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HTR2C—obesity	3.98e-05	0.000215	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DRD1—obesity	3.98e-05	0.000215	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NCOA1—obesity	3.94e-05	0.000213	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP19A1—obesity	3.88e-05	0.00021	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—STK11—obesity	3.88e-05	0.00021	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NTRK2—obesity	3.88e-05	0.000209	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRB1—obesity	3.86e-05	0.000208	CbGpPWpGaD
Tyloxapol—LPL—Disease—FOXO1—obesity	3.84e-05	0.000207	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PARP1—obesity	3.78e-05	0.000204	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GHRL—obesity	3.78e-05	0.000204	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DRD4—obesity	3.75e-05	0.000202	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—STAT3—obesity	3.65e-05	0.000197	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—COMT—obesity	3.61e-05	0.000195	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CNR1—obesity	3.58e-05	0.000193	CbGpPWpGaD
Tyloxapol—LPL—Disease—PRKCD—obesity	3.57e-05	0.000192	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GNB3—obesity	3.56e-05	0.000192	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARGC1A—obesity	3.56e-05	0.000192	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HMOX1—obesity	3.54e-05	0.000191	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TCF7L2—obesity	3.51e-05	0.00019	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DRD2—obesity	3.49e-05	0.000188	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTHFR—obesity	3.48e-05	0.000188	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GNAS—obesity	3.47e-05	0.000187	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GCG—obesity	3.45e-05	0.000186	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTPN1—obesity	3.45e-05	0.000186	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOB—obesity	3.39e-05	0.000183	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TGFB1—obesity	3.38e-05	0.000183	CbGpPWpGaD
Tyloxapol—LPL—Disease—IRS2—obesity	3.32e-05	0.000179	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRL—obesity	3.3e-05	0.000178	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STK11—obesity	3.25e-05	0.000175	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOE—obesity	3.24e-05	0.000175	CbGpPWpGaD
Tyloxapol—LPL—Disease—CAV1—obesity	3.21e-05	0.000174	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PLG—obesity	3.21e-05	0.000173	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOA1—obesity	3.21e-05	0.000173	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GPX1—obesity	3.16e-05	0.000171	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TNF—obesity	3.16e-05	0.000171	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FOXO3—obesity	3.13e-05	0.000169	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ADRB2—obesity	3.13e-05	0.000169	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CD36—obesity	3.08e-05	0.000166	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SOCS1—obesity	3.08e-05	0.000166	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SOCS3—obesity	3.04e-05	0.000164	CbGpPWpGaD
Tyloxapol—LPL—Disease—BAD—obesity	3.02e-05	0.000163	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GNB3—obesity	2.98e-05	0.000161	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF2—obesity	2.92e-05	0.000158	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTHFR—obesity	2.92e-05	0.000158	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GNAS—obesity	2.9e-05	0.000156	CbGpPWpGaD
Tyloxapol—LPL—Disease—IRS1—obesity	2.89e-05	0.000156	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARA—obesity	2.86e-05	0.000155	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOB—obesity	2.84e-05	0.000153	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AGT—obesity	2.77e-05	0.00015	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCL5—obesity	2.77e-05	0.00015	CbGpPWpGaD
Tyloxapol—LPL—Disease—INS—obesity	2.77e-05	0.00015	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOE—obesity	2.72e-05	0.000147	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CAV1—obesity	2.69e-05	0.000145	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FOXO1—obesity	2.69e-05	0.000145	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RPS6KB1—obesity	2.69e-05	0.000145	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOA1—obesity	2.69e-05	0.000145	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT2—obesity	2.68e-05	0.000145	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CD—obesity	2.57e-05	0.000139	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.57e-05	0.000139	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—IL6—obesity	2.55e-05	0.000138	CbGpPWpGaD
Tyloxapol—LPL—Disease—SERPINE1—obesity	2.55e-05	0.000137	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKCD—obesity	2.5e-05	0.000135	CbGpPWpGaD
Tyloxapol—LPL—Disease—TYK2—obesity	2.48e-05	0.000134	CbGpPWpGaD
Tyloxapol—LPL—Disease—RHOA—obesity	2.46e-05	0.000133	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CG—obesity	2.45e-05	0.000132	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HTR2A—obesity	2.44e-05	0.000132	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—C3—obesity	2.44e-05	0.000132	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3R1—obesity	2.43e-05	0.000131	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS3—obesity	2.43e-05	0.000131	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPARG—obesity	2.37e-05	0.000128	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT1—obesity	2.35e-05	0.000127	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—POMC—obesity	2.33e-05	0.000126	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IRS2—obesity	2.32e-05	0.000125	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—INS—obesity	2.32e-05	0.000125	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AGT—obesity	2.32e-05	0.000125	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LEP—obesity	2.27e-05	0.000123	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOE—obesity	2.27e-05	0.000123	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CAV1—obesity	2.25e-05	0.000122	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOA1—obesity	2.25e-05	0.000121	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTOR—obesity	2.24e-05	0.000121	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CB—obesity	2.24e-05	0.000121	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTGS2—obesity	2.22e-05	0.00012	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ESR1—obesity	2.17e-05	0.000117	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CD—obesity	2.16e-05	0.000116	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—F2—obesity	2.14e-05	0.000116	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PRKCB—obesity	2.14e-05	0.000116	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALB—obesity	2.13e-05	0.000115	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BAD—obesity	2.12e-05	0.000114	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CG—obesity	2.05e-05	0.000111	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NOS3—obesity	2.04e-05	0.00011	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3R1—obesity	2.04e-05	0.00011	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IRS1—obesity	2.03e-05	0.000109	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—POMC—obesity	1.95e-05	0.000105	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—INS—obesity	1.94e-05	0.000105	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCL2—obesity	1.91e-05	0.000103	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CB—obesity	1.88e-05	0.000101	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF1—obesity	1.88e-05	0.000101	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT2—obesity	1.88e-05	0.000101	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS2—obesity	1.86e-05	0.0001	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CD—obesity	1.8e-05	9.73e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SERPINE1—obesity	1.78e-05	9.62e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TYK2—obesity	1.73e-05	9.36e-05	CbGpPWpGaD
Tyloxapol—LPL—Disease—STAT3—obesity	1.73e-05	9.36e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RHOA—obesity	1.72e-05	9.28e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3R1—obesity	1.7e-05	9.19e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOS3—obesity	1.7e-05	9.19e-05	CbGpPWpGaD
Tyloxapol—LPL—Disease—MYC—obesity	1.61e-05	8.7e-05	CbGpPWpGaD
Tyloxapol—LPL—Disease—TGFB1—obesity	1.61e-05	8.68e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CB—obesity	1.57e-05	8.48e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MTOR—obesity	1.57e-05	8.48e-05	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CA—obesity	1.37e-05	7.38e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP9—obesity	1.37e-05	7.37e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK8—obesity	1.33e-05	7.17e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STAT3—obesity	1.21e-05	6.55e-05	CbGpPWpGaD
Tyloxapol—LPL—Disease—IL6—obesity	1.21e-05	6.54e-05	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CA—obesity	1.15e-05	6.18e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MYC—obesity	1.13e-05	6.09e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TGFB1—obesity	1.13e-05	6.08e-05	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT1—obesity	1.12e-05	6.03e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CA—obesity	9.58e-06	5.17e-05	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKT1—obesity	9.36e-06	5.05e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL6—obesity	8.48e-06	4.58e-05	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT1—obesity	7.82e-06	4.22e-05	CbGpPWpGaD
